Ventaira Pharmaceuticals

Specialty pharmaceutical company leveraging science and engineering for more effective medicines.

Launch date

Apr 2000

Employees

Market cap

Enterprise valuation

Columbus Ohio (HQ)

Date	Investors	Amount	Round
Sep 2000	Pfizer	N/A	Series A
Feb 2003	Fletcher Spaght Ventures Merlin Biomed Battelle Memorial Institute TL Ventures Richardson Capital	$22.0m	Series B
Apr 2005	Fletcher Spaght Ventures Battelle Ventures Reservoir Venture Partners Safeguard Scientifics TL Ventures Novitas Capital	$13.5m	Series C
Oct 2007	Battelle Memorial Institute	N/A	Acquisition
Total Funding		$35.5m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Ventaira Pharmaceuticals